Pyrazinamide


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000749 Anemia, Megaloblastic PMID:4731775
MESH:D000756 Anemia, Sideroblastic PMID:5434719
MESH:D000857 Olfaction Disorders PMID:19674115
MESH:D001168 Arthritis PMID:2915734
MESH:D002780 Cholestasis, Intrahepatic PMID:27255380
MESH:D003875 Drug Eruptions PMID:7786350
MESH:D004342 Drug Hypersensitivity PMID:7784827
MESH:D006099 Granuloma PMID:9252856
MESH:D006311 Hearing Disorders PMID:8584531
MESH:D006505 Hepatitis PMID:15773037; PMID:7784827; PMID:9252856
MESH:D006529 Hepatomegaly PMID:22431067
MESH:D006973 Hypertension PMID:9134939
MESH:D006996 Hypocalcemia PMID:4340029
MESH:D007008 Hypokalemia PMID:4340029
MESH:D007565 Jaundice PMID:20879012
MESH:D009120 Muscle Cramp PMID:18232182
MESH:D009135 Muscular Diseases PMID:8918638
MESH:D009212 Myoglobinuria PMID:1803050
MESH:D013921 Thrombocytopenia PMID:5434719
MESH:D015431 Weight Loss PMID:27071702; PMID:28425350; PMID:36878459
MESH:D017114 Liver Failure, Acute PMID:12006469; PMID:16212643
MESH:D017674 Hypophosphatemia PMID:4340029
MESH:D018771 Arthralgia PMID:10214039; PMID:2915734; PMID:377739; PMID:6612796
MESH:D033461 Hyperuricemia PMID:10214039; PMID:18232182
MESH:D047508 Massive Hepatic Necrosis PMID:22431067; PMID:6118518
MESH:D051437 Renal Insufficiency PMID:1803050; PMID:2915734
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:16212643; PMID:20879012; PMID:22431067; PMID:25231249; PMID:27071702; PMID:27933861; PMID:28063906; PMID:28425350; PMID:33814510; PMID:36878459; PMID:4800729; PMID:6118518
MESH:D058625 End Stage Liver Disease PMID:7705802
MESH:D064420 Drug-Related Side Effects and Adverse Reactions PMID:27933861

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.